CVE-2017-17677
published 2021-05-19CVE-2017-17677: BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
PriorityP349high8.8CVSS 3.1
AVNACLPRLUINSUCHIHAH
EPSS
1.33%
67.6th percentile
BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
Affected
1 ranges
| Vendor | Product | Version range | Fixed in |
|---|---|---|---|
| bmc | remedy_mid-tier | — | — |
CVSS provenance
nvdv3.18.8HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
nvdv2.06.5MEDIUMAV:N/AC:L/Au:S/C:P/I:P/A:P
Stop checking back — get the weekly exploitation signal.
Every Monday: what got weaponized or added to CISA KEV in the last seven days — each CVE cross-linked to its PoC, Nuclei template, and detection rule. Free, one email a week, unsubscribe in one click.
No detection rules found.
No public exploits indexed.
No writeups or analysis indexed.
http://bmc.comhttp://remedy.comhttps://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.htmlhttps://seclists.org/fulldisclosure/2017/Oct/52http://bmc.comhttp://remedy.comhttps://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.htmlhttps://seclists.org/fulldisclosure/2017/Oct/52
2021-05-19
Published